Carregant...
Mechanisms of Glucocorticoid Resistance in Hypereosinophilic Syndromes
BACKGROUND: Glucocorticoids (GC) are considered first-line therapy for most patients with hypereosinophilic syndrome (HES). Although response rates are generally high, many patients require moderate to high doses for control of eosinophilia and symptoms, and up to 15% of patients do not respond at a...
Guardat en:
| Publicat a: | Clin Exp Allergy |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6910955/ https://ncbi.nlm.nih.gov/pubmed/31657082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cea.13509 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|